Gary W. Elmer

5.6k total citations · 2 hit papers
58 papers, 4.2k citations indexed

About

Gary W. Elmer is a scholar working on Infectious Diseases, Molecular Biology and Food Science. According to data from OpenAlex, Gary W. Elmer has authored 58 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 21 papers in Molecular Biology and 17 papers in Food Science. Recurrent topics in Gary W. Elmer's work include Clostridium difficile and Clostridium perfringens research (23 papers), Probiotics and Fermented Foods (16 papers) and Gut microbiota and health (14 papers). Gary W. Elmer is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (23 papers), Probiotics and Fermented Foods (16 papers) and Gut microbiota and health (14 papers). Gary W. Elmer collaborates with scholars based in United States, France and South Korea. Gary W. Elmer's co-authors include Lynne V. McFarland, Christina M. Surawicz, Richard N. Greenberg, Robert Fekety, Maury E. Mulligan, Moshe Rubin, Gerald van Belle, Karen Bowen, René H. Levy and Gail D. Anderson and has published in prestigious journals such as JAMA, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

Gary W. Elmer

55 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease

2002 561 citations Lynne V. McFarland, Gary W. Elmer et al. The American Journal of Gastroenterology profile →
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study

1989 419 citations Christina M. Surawicz, Gary W. Elmer et al. Gastroenterology profile →

Peers

Gary W. Elmer

EPIDE

GASTR

S. P. Borriello United Kingdom

Els van Nood Netherlands

Rodrigo Bibiloni Switzerland

Alexander Rodriguez‐Palacios United States

Vicky De Preter Belgium

Longxian Lv China

Federica Del Chierico Italy

Joshua Z. Goldenberg United States

Jean‐Jacques Gratadoux France

Heikki Arvilommi Finland

S. P. Borriello United Kingdom

Gary W. Elmer

3.0k ×1.2

1.4k ×0.9

EPIDE

1.5k ×1.3

725 ×0.6

429 ×0.7

GASTR

Citations per year, relative to Gary W. Elmer Gary W. Elmer (= 1×) peers S. P. Borriello

Countries citing papers authored by Gary W. Elmer

Since Specialization

Citations

This map shows the geographic impact of Gary W. Elmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. Elmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. Elmer more than expected).

Fields of papers citing papers by Gary W. Elmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. Elmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. Elmer. The network helps show where Gary W. Elmer may publish in the future.

Co-authorship network of co-authors of Gary W. Elmer

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. Elmer. A scholar is included among the top collaborators of Gary W. Elmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. Elmer. Gary W. Elmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Gail D., Gary W. Elmer, Diana M. Taibi, et al.. (2010). Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women. Phytotherapy Research. 24(10). 1442–1446. 15 indexed citations

Taibi, Diana M., et al.. (2008). A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia. Sleep Medicine. 10(3). 319–328. 69 indexed citations

Li, Yu‐I, Gary W. Elmer, & Renee Leboeuf. (2008). Tanshinone IIA reduces macrophage death induced by hydrogen peroxide by upregulating glutathione peroxidase. Life Sciences. 83(15-16). 557–562. 49 indexed citations

Cech, Nadja B., et al.. (2006). Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells. International Immunopharmacology. 6(7). 1214–1221. 50 indexed citations

Mohutsky, Michael A., Gail D. Anderson, John W. Miller, & Gary W. Elmer. (2006). Ginkgo biloba: Evaluation of CYP2C9 Drug Interactions In Vitro and In Vivo. American Journal of Therapeutics. 13(1). 24–31. 54 indexed citations

Anderson, Gail D., Gary W. Elmer, Eric D. Kantor, Ian E. Templeton, & Michael V. Vitiello. (2005). Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects. Phytotherapy Research. 19(9). 801–803. 30 indexed citations

McFarland, Lynne V., Gary W. Elmer, & Christina M. Surawicz. (2002). Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease. The American Journal of Gastroenterology. 97(7). 1769–1775. 561 indexed citations breakdown →

Krone, Cheryl A., et al.. (2001). Does gastrointestinal Candida albicans prevent ubiquinone absorption?. Medical Hypotheses. 57(5). 570–572. 3 indexed citations

Elmer, Gary W. & Lynne V. McFarland. (2001). BIOTHERAPEUTIC AGENTS IN THE TREATMENT OF INFECTIOUS DIARRHEA. Gastroenterology Clinics of North America. 30(3). 837–854. 43 indexed citations

10.

Surawicz, Christina M., Lynne V. McFarland, Richard N. Greenberg, et al.. (2000). The Search for a Better Treatment for RecurrentClostridium difficileDisease: Use of High‐Dose Vancomycin Combined withSaccharomyces boulardii. Clinical Infectious Diseases. 31(4). 1012–1017. 394 indexed citations

11.

Levy, Drew, Andy Stergachis, Lynne V. McFarland, et al.. (2000). Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. Clinical Therapeutics. 22(1). 91–102. 62 indexed citations

12.

McFarland, Lynne V., Christina M. Surawicz, Moshe Rubin, et al.. (1999). Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics. Infection Control and Hospital Epidemiology. 20(1). 43–50. 287 indexed citations

13.

Elmer, Gary W.. (1996). Biotherapeutic Agents. JAMA. 275(11). 870–870. 143 indexed citations

14.

McFarland, Lynne V., Gary W. Elmer, Walter E. Stamm, & Maury E. Mulligan. (1991). Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients. Infection and Immunity. 59(7). 2456–2462. 63 indexed citations

15.

Elmer, Gary W. & Gérard Corthier. (1991). Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice. Canadian Journal of Microbiology. 37(4). 315–317. 31 indexed citations

16.

Kimmey, Michael B., et al.. (1990). Prevention of further recurrences ofClostridium difficile colitis withSaccharomyces boulardii. Digestive Diseases and Sciences. 35(7). 897–901. 51 indexed citations

17.

Surawicz, Christina M., et al.. (1989). Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology. 96(4). 981–988. 419 indexed citations breakdown →

18.

Bléhaut, Henri, Jean Massot, Gary W. Elmer, & René H. Levy. (1989). Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharmaceutics & Drug Disposition. 10(4). 353–364. 123 indexed citations

19.

Remmel, Rory P., L R Pohl, & Gary W. Elmer. (1981). Influence of the intestinal microflora on the elimination of warfarin in the rat.. Drug Metabolism and Disposition. 9(5). 410–414. 16 indexed citations

20.

Elmer, Gary W., et al.. (1978). Increased tyrosine phenol-lyase activity in mice following pyridoxal phosphate administration.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 1). 3663–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact